— Know what they know.
Not Investment Advice

ODYY OTC

Odyssey Health, Inc.
1W: -12.6% 1M: -14.4% 3M: +38.3% YTD: -74.8% 1Y: -81.2% 3Y: -90.0% 5Y: -97.8%
$0.01
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Devices · Tech Score Sell · Power 40 · $807749 mcap · 85M float · 0.219% daily turnover · Short 70% of daily vol
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.8M
52W Range0.004-0.125
Volume20,000
Avg Volume186,576
Beta-1.39
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOJoseph Michael Redmond
Employees2
SectorHealthcare
IndustryMedical - Devices
IPO Date2021-01-08
2300 West Sahara Avenue
Las Vegas, NV 89102
US
702-780-6559
About Odyssey Health, Inc.

Odyssey Health, Inc. operates as a medical enterprise, primarily focused on the innovation and development of diverse healthcare products. Its current portfolio encompasses CardioMap, an advanced device for cardiac monitoring and screening, alongside the "Save A Life" line of devices engineered for choking emergencies. Additionally, the company is advancing neurosteroid drug compounds, PRV-001 and PRV-002, intended for the treatment of concussive injuries and various rare brain disorders. The organization, established in 2014 and headquartered in Las Vegas, Nevada, was previously known as Odyssey Group International, Inc.

Recent Insider Trades

NameTypeSharesPriceDate
FARRELL CHRISTINE A-Award 500,000 $0.10 2024-06-28
RICHARDSON RICKY A-Award 300,000 $0.10 2024-06-28
Casey Jerome H A-Award 300,000 $0.10 2024-06-28
REDMOND J MICHAEL A-Award 500,000 $0.10 2024-06-28
Gironda Gregory W A-Award 250,000 $0.10 2024-06-28

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms